Carotid Intima-Media Thickness: A Surrogate Marker for Cardiovascular Disease in Chronic Kidney Disease Patients

Olutoyin Morenike Lawal1, Michael Olabode Balogun2, Anthony Olubunmi Akintomide2

  • 1Department of Medicine, State Specialist Hospital, Akure, Nigeria.

Insights

Patients with chronic kidney disease (CKD) show significantly higher carotid intima-media thickness (CIMT), a marker of atherosclerosis. Early CIMT assessment in CKD patients may help identify those needing aggressive treatment for cardiovascular disease (CVD).

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Medicine

Background:

  • Cardiovascular disease (CVD) is the primary cause of death in chronic kidney disease (CKD) patients.
  • Carotid intima-media thickness (CIMT) reflects atherosclerotic vascular disease and cumulative effects of cardiovascular risk factors on arterial walls.
  • This study aimed to assess CIMT in CKD patients and evaluate CVD prevalence and clinical patterns.

Purpose of the Study:

  • To determine the carotid intima-media thickness (CIMT) in patients with chronic kidney disease (CKD).
  • To evaluate the clinical pattern and prevalence of cardiovascular disease (CVD) in CKD patients.

Main Methods:

  • A case-control study included 50 patients with CKD (stages 2-4) and 50 matched healthy controls.
  • Carotid intima-media thickness (CIMT) was measured; >0.8 mm defined thickening.
  • Laboratory tests, ECG, echocardiography, and ankle-brachial index were performed on all participants.

Main Results:

  • Mean CIMT was significantly higher in CKD patients versus controls (P < .001).
  • Eighty-four percent of CKD patients had thickened CIMT compared to 18% of controls (P < .001).
  • CKD patients exhibited higher blood pressure, heart rate, and CVD prevalence. CIMT correlated positively with age, blood pressure, and blood sugar.

Conclusions:

  • Carotid intima-media thickness (CIMT) is a reliable surrogate marker for cardiovascular disease (CVD) in chronic kidney disease (CKD) patients.
  • Early CIMT assessment can identify CKD patients requiring intensified therapy to slow kidney disease progression and improve outcomes.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
597
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
578
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
359
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
331
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
426
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K